Frontiers Case report: Short-term eculizumab use in atypical HUS

PDF) Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing

PDF] Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab

PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome

Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era

PDF) Atypical hemolytic uremic syndrome in a patient with protein-losing enteropathy

Frontiers Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19

Eculizumab Use for Kidney Transplantation in Patients With a Diagnosis of Atypical Hemolytic Uremic Syndrome - ScienceDirect

Frontiers Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation

Frontiers Publishing Partnerships First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient

The treatment of atypical hemolytic uremic syndrome with eculizumab in pediatric patients: a systematic review

PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome

PDF] Pathogenesis of Atypical Hemolytic Uremic Syndrome

Defining treatment duration in atypical hemolytic uremic syndrome in adults: a clinical and pathological approach.